Try our Advanced Search for more refined results
March 21, 2005
Track this case
Other Statutory Actions
Marcia A. Crone
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Kidney care provider DaVita Inc. said Monday it had reached a $55 million settlement agreement in a qui tam False Claims Act suit alleging it fraudulently billed the federal government for free supplies of Amgen Inc.’s anemia drug Epogen.
Already a subscriber? Click here to login